General Updates

GUJARAT THEMIS BIOSYN LIMITED CIN: L24230GJ1981PLC004878 REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE, VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA TEL: 0260-2430027 / 2400639, E-mail: hrm@gtbl.in.net September 16, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street Bandra Kurla Complex Mumbai 400001 Bandra East, Mumbai 400051 Symbol: GUJTHEM Scrip Code: 506879 Dear Sir / Madam, Sub.: Disclosure pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. We refer to our disclosure dated 10th September 2026 informing about the approval accorded by the Board of the Company for the issuance of Non-Convertible Debentures (NCDs). This is to inform you that the Committee of the Board of Directors of the Company at its meeting held on September 16, 2026, has allotted Non-Convertible Debentures (NCDs) aggregating INR 585 Crores on private placement basis. The Company is utilizing the NCDs proceeds inter alia for investing in its wholly subsidiary in Japan to finance the acquisition of MicroBiopharm Japan Co., Ltd, and general corporate purpose. Prescribed details about the NCDs are in the annexure attached herewith. The above disclosure is pursuant to applicable provisions / Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 / applicable laws. Thanking you Yours faithfully For Gujarat Themis Biosyn Limited Vineet Gawankar Company Secretary & Compliance Officer Encl.: As above GUJARAT THEMIS BIOSYN LIMITED Annexure (Details of NCDs) No. Description Particulars 1 Type of securities proposed to be issued Secured, redeemable, unlisted, rated, non- convertible debentures (NCDs), each having a nominal value of INR 1,00,000 (Indian Rupees One Lakh) 2 Type of issuance Private Placement 3 Total number of securities proposed to be The Committee has allotted 58,500 NCDs, each issued or the total amount for which the having a nominal value of INR 1,00,000 securities will be issued; aggregating INR 5,850,000,000 (Indian Rupees Five Hundred and Eighty-Five Crores), comprising: (i) up to 29,500 NCDs aggregating INR 2,950,000,000 (NCD Series 1); and (ii) 29,000 4 Size of the issue NCDs aggregating INR 2,900,000,000 (NCD Series 2) (NCD Series 1 and NCD Series 2 being collectively referred to as the “NCDs” or “Debentures”). 5 Whether proposed to be listed? Name No of the Stock Exchange(s) 6 Tenure of the Instrument - Date of Series 1: 60 (sixty) months from the Effective Date Allotment and Date of Maturity Series 2: 18 (eighteen) months from the Effective Date 7 Coupon /Interest offered, Schedule Series 1: 10% p.a. compounded monthly. Coupon of payment of coupon/interest and payable quarterly, with the first Coupon Period principal commencing from (and including) the first date of the 13th month from the Deemed Date of Allotment and ending on the last date of the 15th month from the Deemed Date of Allotment and each successive period of 3 months commencing immediately after the expiry of the first Coupon Payment Date, provided however that the last Coupon Period shall end on the Final Settlement Date. Series 2: 17.75% p.a. compounded monthly. Coupon payable quarterly, with the first Coupon Period commencing from the (and including) the first date of the 13th month from the Deemed Date of Allotment and ending on the last date of the 15th month from the Deemed Date of Allotment and each successive period of 3 months commencing immediately after the expiry of the first Coupon Payment Date, provided however that the last GUJARAT THEMIS BIOSYN LIMITED Coupon Period shall end on the Final Settlement Date. 8 Charge/Security, if any, created over Secured on assets of the Company as per the the assets Debenture Truste Deed dated 12.09.2026 (DTD) including (a) first ranking pari passu charge by way of hypothecation over movable fixed assets and brands (with related intellectual property rights), present and future ; (b) first ranking pari passu mortgage over immovable fixed assets owned by the Company including by way of lease interest, present and future; (c) second ranking pari passu charge by way of hypothecation over all present and future current assets of the Company; (d) first ranking pari passu charge over the Escrow Account, cashflows and receivables of the Company; (e) personal guarantee provided by Dr. Sachin Patel, Promoter; and (f) demand promissory note and related letter of continuity in connection to the Secured Obligations. 9 Special right / interest / privileges Not Applicable attached to the instrument and changes thereof 10 Delay in payment of interest / principal Not Applicable amount for a period of more than three months from the due date or default in payment of interest / principal 11 Details of any letter or comments Not Applicable regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if 12 Details of redemption of preference shares Not Applicable indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures 13 Any cancellation or termination of Not Applicable proposal for issuance of securities including reasons thereof